Literature DB >> 27769960

Response to: 'Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use' by van den Hoogen et al.

Srilakshmi Yalavarthi1, Robert C Grenn1, Jason S Knight1.   

Abstract

Entities:  

Keywords:  Antiphospholipid Syndrome; Disease Activity; Treatment

Mesh：

Substances：

Year:  2016        PMID： 27769960      PMCID： PMC5534262          DOI： 10.1136/annrheumdis-2016-210529

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Low-Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti-β2 -Glycoprotein I Antibodies: Comment on the Article by Yalavarthi et al.

Authors:  L L van den Hoogen; R D E Fritsch-Stork; J A G van Roon; T R D J Radstake
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

2.  Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.

Authors:  Robert C Grenn; Srilakshmi Yalavarthi; Alex A Gandhi; Nayef M Kazzaz; Carlos Núñez-Álvarez; Diego Hernández-Ramírez; Antonio R Cabral; W Joseph McCune; Paula L Bockenstedt; Jason S Knight
Journal:  Ann Rheum Dis       Date:  2016-07-18       Impact factor: 19.103

3.  Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use.

Authors:  Lucas L van den Hoogen; Ruth D E Fritsch-Stork; Marjan A Versnel; Ronald H Wm Derksen; Joël A G van Roon; Timothy R Dj Radstake
Journal:  Ann Rheum Dis       Date:  2016-09-28       Impact factor: 19.103

4.  Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.

Authors:  Carlos Perez-Sanchez; Nuria Barbarroja; Sebastiano Messineo; Patricia Ruiz-Limon; Antonio Rodriguez-Ariza; Yolanda Jimenez-Gomez; Munther A Khamashta; Eduardo Collantes-Estevez; M Jose Cuadrado; M Angeles Aguirre; Chary Lopez-Pedrera
Journal:  Ann Rheum Dis       Date:  2014-03-11       Impact factor: 19.103

5.  Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.

Authors:  Srilakshmi Yalavarthi; Travis J Gould; Ashish N Rao; Levi F Mazza; Alexandra E Morris; Carlos Núñez-Álvarez; Diego Hernández-Ramírez; Paula L Bockenstedt; Patricia C Liaw; Antonio R Cabral; Jason S Knight
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

6.  Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.

Authors:  Carolyne K Smith; Anuradha Vivekanandan-Giri; Chongren Tang; Jason S Knight; Anna Mathew; Robin L Padilla; Brenda W Gillespie; Carmelo Carmona-Rivera; Xiaodan Liu; Venkataraman Subramanian; Sarfaraz Hasni; Paul R Thompson; Jay W Heinecke; Rajiv Saran; Subramaniam Pennathur; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995
  6 in total
  1 in total

Review 1.  Antiphospholipid syndrome: an update for clinicians and scientists.

Authors:  Andrew P Vreede; Paula L Bockenstedt; Jason S Knight
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.